NYSE · BHC
Bausch Health Companies Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for BHC has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $1.16 | $1.17 | $1.16 | 2 |
| Mar 2027 | $0.86 | $0.87 | $0.84 | 2 |
| Jun 2027 | $0.97 | $1.03 | $0.91 | 2 |
| Sep 2027 | $1.06 | $1.07 | $1.04 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · The Motley Fool · Fintel- RTTNews · Oct 29, 3:40 PM EDTHealthcare Stocks Rise: GKOS Surges 33%, TDOC Gains 30%, BHC Advances 26%, MESO Jumps Over 16%(RTTNews) – Shares of several healthcare companies moved higher following quarterly financial results and business updates. Glaukos raised its 2026 sales guidance and issued a preliminary outlook for 2027, Teladoc Health reported improved adjusted EBITDA, Bausch Health posted hig
- Zacks · Oct 29, 9:43 AM EDTBHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook RisesBausch Health shares jump 9% as Q3 earnings top estimates, driven by Xifaxan-led Salix growth, improved profitability and raised 2026 guidance.
- The Motley Fool · Oct 29, 12:43 AM EDTBausch Health (BHC) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Oct 28, 8:12 PM EDTBausch Health Companies Inc. Reports Third Quarter 2026 Consolidated Revenues of $2.94 billionBausch Health Companies Inc. reported third quarter 2026 consolidated revenues of $2.94 billion, representing an increase of 10% on a reported basis and 8% on an organic basis compared to the third quarter of 2025. GAAP net income attributable to Bausch Health was $436 million, o
- MarketBeat · Oct 28, 8:04 PM EDTWhat Bausch Health Cos (BHC) Said on Its Q3 Earnings CallBausch Health: A Buyout Bid Could Be the Ticket to Unlock ValueBausch Health Cos (NYSE:BHC) raised its full-year 2026 outlook for the second consecutive quarter after reporting third-quarter growth across its operating segments, led by Salix and supported by international operati
- Zacks · Oct 28, 6:30 PM EDTBausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesBausch (BHC) delivered earnings and revenue surprises of +63.89% and +7.11%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 28, 6:30 PM EDTBausch (BHC) Reports Q3 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- RTTNews · Oct 28, 4:07 PM EDTBausch Health Companies Inc. Q3 Profit Climbs(RTTNews) – Bausch Health Companies Inc. (BHC.TO) announced earnings for its third quarter that Increases, from the same period last year
- Zacks · Oct 26, 1:33 PM EDTBHC Q3 Earnings Preview: Here's What You Should KnowBausch Health reports Q3 2026 results on Oct. 28, with $2.75 billion in expected sales. Explore key segment drivers and mixed earnings surprise history.
- RTTNews · Oct 19, 11:57 AM EDTBausch Health Broadens Access To Long-Acting Schizophrenia Treatment In Canada(RTTNews) – Bausch Health Canada Inc., a subsidiary of Bausch Health Companies Inc. (BHC), announced expanded public reimbursement for PrOKEDI (risperidone extended-release injectable suspension) 75 mg and 100 mg for the treatment of schizophrenia in adults.
- RTTNews · Oct 12, 9:45 AM EDTBausch Health Pilot Study Shows Improved Cirrhosis Care Adherence(RTTNews) – Bausch Health Companies Inc. (BHC, BHC.TO) and its gastroenterology unit Salix Pharmaceuticals, announced on Monday that a six-month pilot study of a standardized clinical pathway for Cirrhosis management improved adherence to guideline-based monitoring and treatment
- Zacks · Oct 5, 8:29 AM EDTThe Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health CompaniesHealthcare stocks like Abbott Laboratories offer low-beta exposure as rate hike fears and inflation keep markets volatile.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Bausch Health Companies Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.